IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

AMRI extends API supply deal with Shire

8:34 AM MDT | October 19, 2012 | Deepti Ramesh

Albany Molecular Research Inc. (AMRI; Albany) says it has entered into a mult-year active pharmaceutical ingredient (API) supply agreement for an undisclosed product with Shire US Manufacturing (Owings Mills, MD), a subsidiary of specialty biopharmaceutical company Shire (Dublin). The terms of the deal were not disclosed. The agreement extends a previously existing agreement between the two companies, AMRI says. Shire focuses its business on behavioral health, gastrointestinal diseases, rare diseases, and regenerative medicine, AMRI says. “We are pleased to...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa